Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia
/in Chronic Leukemia, International Publications /von 2007-04-04 / Br. J. Haematol. 2007 May;137(4):297-306Dendritic cell vaccines for leukemia patients
/in Acute Leukemia, Chronic Leukemia, International Publications /von 2007-03-01 / Expert Rev Anticancer Ther 2007 Mar;7(3):275-83Current status of immunotherapy in B cell malignancies
/in Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-4Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies
/in Chronic Leukemia, International Publications, Malignant Lymphoma /von 2006-04-01 / Leuk. Lymphoma 2006 Apr;47(4):675-82Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation
/in Chronic Leukemia, International Publications /von 2006-03-09 / Leuk. Res. 2006 Jul;30(7):785-94Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation
/in Chronic Leukemia, International Publications /von 2006-02-03 / J. Leukoc. Biol. 2006 Apr;79(4):747-56Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate
/in Chronic Leukemia, International Publications /von 2006-02-01 / Leuk. Lymphoma 2006 Feb;47(2):297-306Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2006-01-01 / Cytotherapy 2006;8(4):318-26Vaccine strategies to treat lymphoproliferative disorders
/in Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2005-12-01 / Pathology 2005 Dec;37(6):534-50IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de